About Precia Pharma
Precia Pharma is a company based in India founded in 2011. The company has 1 employees as of April 08, 2024. Precia Pharma offers products and services including EndoFormin and MyloNerv.
- Headquarter India
- Employees 1 as on 08 Apr, 2024
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Social
Locked
- Legal Name Precia Pharma Private Limited
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$1.49 M (USD)-23.05as on Mar 31, 2021
-
Net Profit
-$494.48 K (USD)45.95as on Mar 31, 2021
-
EBITDA
-$221.83 K (USD)66.4as on Mar 31, 2021
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
1
as on Apr 08, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precia Pharma
Precia Pharma offers a comprehensive portfolio of products and services, including EndoFormin and MyloNerv.
EndoFormin is provided as a metformin-based product utilizing Ultra High Viscosity Matrix Technology for uniform drug delivery over an extended period in a smaller tablet size.
MyloNerv is offered as a comprehensive formula containing double strength ALA 200 mg to support neuron recharging for therapeutic purposes in tablet form.
Funding Insights of Precia Pharma
Detailed funding history for Precia Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Precia Pharma
Investment portfolio details for Precia Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Precia Pharma
Detailed financials for Precia Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Precia Pharma Comparisons
Peer comparison for Precia Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Precia Pharma
Detailed competitors of Precia Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Precia Pharma
Complete news archive for Precia Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Precia Pharma
Precia Pharma was founded in 2011.
Precia Pharma is headquartered in India.
As of Apr 08, 2024, the latest employee count at Precia Pharma is 1.
Annual revenue of Precia Pharma is $1.49M as on Mar 31, 2021.
Precia Pharma Private Limited is recognized as a pharmaceutical company that was established in May 2010 and began operations in October 2011, with a vision to serve as a preferred partner in the global healthcare industry. It is noted for its commitment to innovative solutions in patient care, sourcing quality products from WHO-approved plants, and developing brands for lifestyle diseases such as diabetes and neuropathy. Awards have been received by the company for its excellence, and it operates in segments like cardiology and anti-obesity, emphasizing product development driven by experienced professionals.
Precia Pharma offers EndoFormin and MyloNerv.